I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 21% ± 7% | |
| fibroblast | 8 studies | 24% ± 9% | |
| epithelial cell | 6 studies | 37% ± 18% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 19% ± 4% | |
| hematopoietic precursor cell | 5 studies | 27% ± 6% | |
| abnormal cell | 5 studies | 25% ± 7% | |
| ciliated cell | 5 studies | 30% ± 8% | |
| macrophage | 4 studies | 22% ± 3% | |
| astrocyte | 4 studies | 21% ± 4% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| goblet cell | 4 studies | 23% ± 4% | |
| basal cell | 4 studies | 26% ± 8% | |
| pancreatic A cell | 3 studies | 29% ± 10% | |
| plasmablast | 3 studies | 36% ± 18% | |
| myeloid cell | 3 studies | 22% ± 6% | |
| pericyte | 3 studies | 18% ± 2% | |
| type I pneumocyte | 3 studies | 24% ± 4% | |
| GABAergic neuron | 3 studies | 35% ± 5% | |
| glutamatergic neuron | 3 studies | 38% ± 9% | |
| dendritic cell | 3 studies | 27% ± 7% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
| granulocyte monocyte progenitor cell | 3 studies | 24% ± 7% | |
| enteroendocrine cell | 3 studies | 20% ± 4% | |
| transit amplifying cell | 3 studies | 27% ± 4% | |
| connective tissue cell | 3 studies | 27% ± 12% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 3% | |
| erythroblast | 3 studies | 27% ± 8% | |
| oligodendrocyte | 3 studies | 16% ± 0% |
